Bahrain Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus
Condition:   Diabetes Mellitus, Type 2 Intervention:   Drug: ORMD-0801 Sponsors:   King Hamad University Hospital, Bahrain;   Royal College of Surgeons in Ireland - Medical University of Bahrain;   Oramed, Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2021 Category: Research Source Type: clinical trials